Fiduxosin Hydrochloride

N/A

Report date: 2024/10/17 17:05:43
NME

Base Information

Drug NameFiduxosin Hydrochloride
Drug Alias Namefiduxosina非度索嗪非多唑嗪fiduxosinefiduxosinum +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenoceptor Alpha 1D antagonistsAlpha-1a adrenergic receptor antagonists
TargetsAdrenoceptor Alpha 1DAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksKEGG